UroGen Pharma Total Assets (Quarterly) Insights

UroGen Pharma Ltd (URGN)

13.31 +0.04 (+0.30%) USD | NASDAQ | May 22, 16:00

13.30 -0.02 (-0.11%) After-Hours: 20:00

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
March 31, 2024	200.57M
December 31, 2023	178.31M
September 30, 2023	193.63M
June 30, 2023	95.36M
March 31, 2023	112.95M
December 31, 2022	135.62M
September 30, 2022	128.47M
June 30, 2022	146.14M
March 31, 2022	165.72M
December 31, 2021	119.75M
September 30, 2021	134.60M
June 30, 2021	153.77M
March 31, 2021	97.41M
December 31, 2020	122.00M
September 30, 2020	139.89M

Date	Value
June 30, 2020	161.08M
March 31, 2020	166.93M
December 31, 2019	202.39M
September 30, 2019	226.75M
June 30, 2019	238.57M
March 31, 2019	252.05M
December 31, 2018	103.56M
September 30, 2018	112.56M
June 30, 2018	121.50M
March 31, 2018	129.40M
December 31, 2017	75.55M
September 30, 2017	81.19M
June 30, 2017	79.04M
December 31, 2016	23.06M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

95.36M

Minimum

Jun 2023

238.57M

Maximum

Jun 2019

156.00M

Average

149.95M

Median

Total Assets (Quarterly) Benchmarks

Agenus Inc	256.56M
Exelixis Inc	2.804B
Geron Corp	482.07M
Protalix BioTherapeutics Inc	89.82M
InfuSystems Holdings Inc	104.85M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	240.71M
Shareholders Equity (Quarterly)	-40.13M
Debt to Equity Ratio	-2.432
Current Ratio	7.47
Net Debt Paydown Yield	-0.00%